Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

INSTRUCTIONS: Implementation of a Procainamide-Based Cardioversion Strategy for the Management of Recent-Onset Atrial Fibrillation

INSTRUCTIONS: Implementation of a Procainamide-Based Cardioversion Strategy for the Management of... EARN NCPD CREDIT ONLINE Go to http://www.nursingcenter.com/CE/AENJ and receive a certificate within minutes. INSTRUCTIONS Implementation of a Procainamide-Based Cardioversion Strategy for the Management of Recent-Onset Atrial Fibrillation TEST INSTRUCTIONS PROVIDER ACCREDITATION Read the article. The test for this nursing continuing Lippincott Professional Development will award 2.0 con- professional development (NCPD) activity is to be taken tact hours and 0.0 pharmacology contact hours for this online at www.nursingcenter.com/CE/AENJ. Tests can no nursing continuing professional development activity. longer be mailed or faxed. Lippincott Professional Development is accredited as a You’ll need to create an account (it’s free!) and log in to provider of nursing continuing professional development access My Planner before taking online tests. Your planner by the American Nurses Credentialing Center’s Commis- will keep track of all your Lippincott Professional Develop- sion on Accreditation. ment online NCPD activities for you. This activity is also provider approved by the Califor- There’s only one correct answer for each question. A nia Board of Registered Nursing, Provider Number CEP passing score for this test is 7 correct answers. If you pass, 11749 for 2.0 contact hours. Lippincott Professional De- you can print your certificate of earned contact hours and velopment is also an approved provider of continuing access the answer key. If you fail, you have the option of nursing education by the District of Columbia, Georgia, taking the test again at no additional cost. and Florida, CE Broker #50-1223. Your certificate is valid For questions, contact Lippincott Professional Develop- in all states. ment: 1-800-787-8985. Payment: The registration fee for this test is $21.95. Registration deadline is September 6, 2024. AENJ0721A CE TEST QUESTIONS Learning Outcome: Health care providers will 3. Results of this study indicated that 7. Compared with patients who did not demonstrate knowledge of a retrospective chart review 60.9% of patients achieve successful cardioversion fol- assessing the safety and efficacy of intravenous pro- a. were admitted to the hospital. lowing procainamide therapy, those cainamide for pharmacological cardioversion in patients b. achieved successful cardioversion. who did were presenting to the emergency department (ED) with atrial c. returned to the ED with chest pain. a. as likely to receive a rate control agent. fibrillation of less than 48 hoursʼ duration by achiev- b. less likely to receive a rate control agent. 4. Adverse effects of procainamide oc- ing a minimum score of 70% on the outcomes-based c. more likely to receive a rate control agent. curred in 9.4% of patients, the most posttest. common of which was 8. Compared with patients who did not Learning Objectives: After completing this con- a. drowsiness. achieve cardioversion following pro- tinuing professional development activity, the participant b. hypotension. cainamide therapy, those who did will be able to apply knowledge gained to: c. tachyarrhythmias. had 1. Recognize the evidence that supports the need for a. a lower percentage of 30-day ED return visits this study of the safety and efficacy of intravenous 5. Of the patients whose records were for serious adverse events. procainamide for pharmacological cardioversion. examined, 20.3% patients returned to b. a higher percentage of 30-day ED return visits 2. Choose the results of this study that can help lend the ED within 30 days with for serious adverse events. insight for clinicians establishing and following pro- a. AF. c. about the same percentage of 30-day ED return tocols for the use of this therapy. b. syncope. visits for serious adverse events. 1. The mainstay of therapy in the United c. vomiting. States for atrial fibrillation/flutter (AF) 9. Compared with the hospital admis- 6. Patients who were successfully car- is sion rates in this study, those in pre- dioverted were about half as likely to a. rate control. vious studies were a. require electrical cardioversion. b. chemical cardioversion. a. substantially lower. b. develop other arrhythmias. c. electrical cardioversion. b. substantially higher. c. be admitted to the hospital. c. approximately the same. 2. According to Stiell et al. (2017) and others, acute pharmacological car- 10. The known side effects of pro- dioversion has consistently shown a cainamide include less than 1% risk of a. diuresis. a. myocardial infarction. b. insomnia. b. pulmonary embolism. c. bradycardia. c. stroke. E5 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advanced Emergency Nursing Journal Wolters Kluwer Health

INSTRUCTIONS: Implementation of a Procainamide-Based Cardioversion Strategy for the Management of Recent-Onset Atrial Fibrillation

Advanced Emergency Nursing Journal , Volume 43 (3) – Jul 1, 2021

Loading next page...
 
/lp/wolters-kluwer-health/instructions-implementation-of-a-procainamide-based-cardioversion-LZ7b00UJX6
Publisher
Wolters Kluwer Health
Copyright
© 2021 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1931-4485
eISSN
1931-4493
DOI
10.1097/tme.0000000000000368
Publisher site
See Article on Publisher Site

Abstract

EARN NCPD CREDIT ONLINE Go to http://www.nursingcenter.com/CE/AENJ and receive a certificate within minutes. INSTRUCTIONS Implementation of a Procainamide-Based Cardioversion Strategy for the Management of Recent-Onset Atrial Fibrillation TEST INSTRUCTIONS PROVIDER ACCREDITATION Read the article. The test for this nursing continuing Lippincott Professional Development will award 2.0 con- professional development (NCPD) activity is to be taken tact hours and 0.0 pharmacology contact hours for this online at www.nursingcenter.com/CE/AENJ. Tests can no nursing continuing professional development activity. longer be mailed or faxed. Lippincott Professional Development is accredited as a You’ll need to create an account (it’s free!) and log in to provider of nursing continuing professional development access My Planner before taking online tests. Your planner by the American Nurses Credentialing Center’s Commis- will keep track of all your Lippincott Professional Develop- sion on Accreditation. ment online NCPD activities for you. This activity is also provider approved by the Califor- There’s only one correct answer for each question. A nia Board of Registered Nursing, Provider Number CEP passing score for this test is 7 correct answers. If you pass, 11749 for 2.0 contact hours. Lippincott Professional De- you can print your certificate of earned contact hours and velopment is also an approved provider of continuing access the answer key. If you fail, you have the option of nursing education by the District of Columbia, Georgia, taking the test again at no additional cost. and Florida, CE Broker #50-1223. Your certificate is valid For questions, contact Lippincott Professional Develop- in all states. ment: 1-800-787-8985. Payment: The registration fee for this test is $21.95. Registration deadline is September 6, 2024. AENJ0721A CE TEST QUESTIONS Learning Outcome: Health care providers will 3. Results of this study indicated that 7. Compared with patients who did not demonstrate knowledge of a retrospective chart review 60.9% of patients achieve successful cardioversion fol- assessing the safety and efficacy of intravenous pro- a. were admitted to the hospital. lowing procainamide therapy, those cainamide for pharmacological cardioversion in patients b. achieved successful cardioversion. who did were presenting to the emergency department (ED) with atrial c. returned to the ED with chest pain. a. as likely to receive a rate control agent. fibrillation of less than 48 hoursʼ duration by achiev- b. less likely to receive a rate control agent. 4. Adverse effects of procainamide oc- ing a minimum score of 70% on the outcomes-based c. more likely to receive a rate control agent. curred in 9.4% of patients, the most posttest. common of which was 8. Compared with patients who did not Learning Objectives: After completing this con- a. drowsiness. achieve cardioversion following pro- tinuing professional development activity, the participant b. hypotension. cainamide therapy, those who did will be able to apply knowledge gained to: c. tachyarrhythmias. had 1. Recognize the evidence that supports the need for a. a lower percentage of 30-day ED return visits this study of the safety and efficacy of intravenous 5. Of the patients whose records were for serious adverse events. procainamide for pharmacological cardioversion. examined, 20.3% patients returned to b. a higher percentage of 30-day ED return visits 2. Choose the results of this study that can help lend the ED within 30 days with for serious adverse events. insight for clinicians establishing and following pro- a. AF. c. about the same percentage of 30-day ED return tocols for the use of this therapy. b. syncope. visits for serious adverse events. 1. The mainstay of therapy in the United c. vomiting. States for atrial fibrillation/flutter (AF) 9. Compared with the hospital admis- 6. Patients who were successfully car- is sion rates in this study, those in pre- dioverted were about half as likely to a. rate control. vious studies were a. require electrical cardioversion. b. chemical cardioversion. a. substantially lower. b. develop other arrhythmias. c. electrical cardioversion. b. substantially higher. c. be admitted to the hospital. c. approximately the same. 2. According to Stiell et al. (2017) and others, acute pharmacological car- 10. The known side effects of pro- dioversion has consistently shown a cainamide include less than 1% risk of a. diuresis. a. myocardial infarction. b. insomnia. b. pulmonary embolism. c. bradycardia. c. stroke. E5

Journal

Advanced Emergency Nursing JournalWolters Kluwer Health

Published: Jul 1, 2021

There are no references for this article.